Keyword: Bayer

News

Bayer Divestment of its MaterialScience Unit ‘Inevitable,’ Analysts Say

30.07.2013 - Expectations that Bayer will embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve. The diversified German healthcare group has an...

News

Europe Backs New Dual-Action Novartis Lung Drug

29.07.2013 - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro...

News

Bayer Confirms 2015 Start for Commercial-Scale CO2 to Polyols Unit

26.07.2013 - Bayer MaterialScience has confirmed 2015 as the start-up date for commercial scale production facility of polyether of polycarbonate polyols made from CO2 feedstock. The new plant...

News

Syngenta’s H1 Earnings Dampened by Wet Spring

25.07.2013 - Syngenta said on Wednesday it expected underlying sales growth to pick up pace in the second half of the year, after a cold, wet spring hit earnings in the first six months...

News

China Blocks GSK Finance Head From Leaving Country

18.07.2013 - Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...

News

BASF Criticizes Inclusion of Fipronil in EU Bee Protection Restrictions

17.07.2013 - BASF has taken issue with the European Union's move to include the group's insecticide fipronil, used in treatment of maize and sunflower seed treatments, in its temporary...

News

Pfizer, Novartis May Join Amgen in Bidding for Onyx

02.07.2013 - Onyx Pharmaceuticals, whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer and...

News

Onyx Rejects Amgen Offer, Explores Possible Sale

01.07.2013 - Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...